Hints and tips:
Related Special Reports
...However, Steensberg stressed his company, which joined forces with German pharma group Boehringer Ingelheim more than a decade ago to develop a weight loss drug that is now in late-stage trials, wanted to...
...German pharma group Boehringer Ingelheim has struck an up to $1bn partnership with a UK biotech to develop treatments for chronic liver disease that aim to harness the organ’s capacity to regenerate....
...Ingelheim....
...On Monday, German company Boehringer Ingelheim announced results showing that its weight-loss treatment delivered strong results for patients suffering from a liver disease, in a sign of how therapies can...
...Impressive results also emerged for German pharma group Boehringer Ingelheim and Zealand Pharma’s survodutide....
...Boehringer Ingelheim said this could be avoided if the dose was increased more slowly in future....
...He now hopes to bring a case to trial alleging that the product — sold by GSK, Sanofi, Pfizer and Boehringer Ingelheim over many years, caused his disease....
...Boehringer Ingelheim is building a new manufacturing plant but, says Dias of the EMA, “you don’t build a new site overnight”....
...It is trialling Survodutide, developed with Boehringer Ingelheim, along with an earlier-stage drug petrelintide. This mimics the amylin hormone, and may have fewer side-effects....
...German pharma group Boehringer Ingelheim is commercialising a Zealand treatment for both obesity and liver disease that is set to launch by 2028....
...The list includes: Jardiance, a diabetes treatment made by Boehringer Ingelheim and Eli Lilly; Eliquis, an anti-stroke medicine made by BMS and Pfizer; and Entresto, a heart failure treatment....
...They include Eliquis, a blood thinner produced by Bristol Myers Squibb (BMS) and its partner Pfizer, the diabetes treatment Jardiance sold by Boehringer Ingelheim and Eli Lilly, and Xarelto, another blood...
...The initial list of 10 drugs to face price negotiations includes a diabetes pill called Jardiance sold by Boehringer Ingelheim and Eli Lilly; a medicine to prevent strokes called Eliquis made by Pfizer and...
...Boehringer Ingelheim declined to comment on the arbitration’s ruling. Sanofi did not immediately respond to requests for comment....
...The ruling was a significant win for the pharmaceutical companies GSK, Pfizer, Sanofi and Boehringer Ingelheim....
...The ruling on Tuesday from a Florida court handed victory to both drugmakers as well as to Pfizer and Boehringer Ingelheim....
...As the lawsuits move towards trial, companies who sold branded versions of Zantac over the past 35 years — including GSK, Sanofi, Pfizer and Boehringer Ingelheim Pharmaceuticals — have denied that using...
...Before that, it was marketed by the private drugmaker Boehringer Ingelheim from 2006 to 2017, Pfizer from 2000 to 2006, and GSK from 1995 to 1998....
...It also works with German drugmaker Boehringer Ingelheim and Juno Therapeutics and Beam Therapeutics in the US....
...“We all agree that we need to rethink how this market works,” says Hubertus von Baumbach, head of German pharmaceutical group Boehringer Ingelheim, and chair of the European Federation of Pharmaceutical...
...The reduced rate brings Mainz in line with nearby Ingelheim — home to Germany’s second-largest pharmaceutical company, Boehringer Ingelheim — and makes the city a far cheaper place to do business than neighbouring...
...of the pharmaceutical company Boehringer Ingelheim....
...A lifeline came from Germany’s biotechnology industry, namely a deal with Boehringer Ingelheim....
...Drugmakers GSK and Boehringer Ingelheim are now rationing inhalers, according to Premier....
International Edition